Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico

• Autors principals: Coral Rosado-Santiago (Autor), Carmen L. Pérez-Guerra (Autor), Nicole M. Vélez-Agosto (Autor), Claudia Colón-Burgos (Autor), Karla M. Marrero-Santos (Autor), Susanna K. Partridge (Autor), Amy E. Lockwood (Autor), Cathy Young (Autor), Steve H. Waterman (Autor), Gabriela Paz-Bailey (Autor), Iris Cardona-Gerena (Autor), Angel Rivera (Autor), Laura E. Adams (Autor), Joshua M. Wong (Autor)
• Format: Llibre
• Publicat: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

ABSTRACTDengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9-16 y with laboratory-confirmed previous dengue infection and living in areas where dengue is endemic. We conducted focus groups with parents and in-depth interviews with key i...